NN
NOVO NORDISK INC.
Organization · DC
Hires government relations
Pharmaceutical company
What they lobby on
FY 2024 appropriations: LHHS Appropriations related to Medicare Part D coverage of anti-obesity medications.
Issues related to Medicare coverage of Anti Obesity Medicines. H.R.4818 / S. 2407 - Treat and Reduce Obesity Act of 2023.
Issues related to insulin. Issues related to pharmaceutical supply chain transparency and integrity. Issues relating to pharmaceutical drug pricing.
Issues related to insulin. Issues related to pharmaceutical supply chain transparency and integrity.